Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

While GLP-1s have become current standard ... two in homozygous ZZ patients. Our proof of mechanism results, meaning ...

Altimmune (ALT) has received a new Buy rating, initiated by UBS analyst, Eliana Merle. Eliana Merle has given her Buy rating due to a ...

Fractyl has nominated its first smart GIP/GLP-1 pancreatic gene therapy lead candidate ... to edit abnormal intestinal ...

The oral presentation "Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves ... to edit abnormal intestinal nutrient sensing and signaling mechanisms that are a potential root ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028 ...

Promising phase 1 data from AZD5004, our small molecule oral GLP-1 receptor agonist ... Additionally, we believe the triple mechanism combination of AZD6234 with AZD9550, our GLP1 glucagon dual ...

Achieved first-ever RNA editing in humans in RestorAATion-2 trial of WVE-006 (GalNAc-AIMer) in alpha-1 antitrypsin deficiency and announced ... for synergistic use with GLP-1s, and for maintenance to ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.